Immupharma (IMM)

 

Latest News

ImmuPharma losses widen

ImmuPharma posts a pre-tax loss of GBP4.5m for the year ended 31 December compared with GBP3.3m in 2014. Revenues ...

Annual Financial Report & Notice of AGM

RNS Number: 1388X Immupharma PLC 04 May 2016 4 MAY 2016 ANNUAL REPORT AND ACCOUNTS NOTICE OF ANNUAL GENERAL MEETING: 26 MAY 2016 ImmuPharma PLC (LSE:IMM) , ("ImmuPharma" or the "Company"), the specialist drug discovery and development company confirms that the Annual Report and Accounts for the year ended ...

Final Results

RNS Number: 1387X Immupharma PLC 04 May 2016 FOR IMMEDIATE RELEASE 4 May 2016 PRELIMINARY RESULTS for the year ended 31 December 2015 ImmuPharma PLC (LSE:IMM) ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, is pleased to announce its preliminary results for the year ended 31 Decembe...

ImmuPharma schedules FY results

ImmuPharma will announce its preliminary results for the year ended 31 December on 4 May. At 9:55am: (LON:IMM) Im...

All News

DateHeadlineSource
04-05-16ImmuPharma losses widenStockMarketWire
04-05-16Annual Financial Report & Notice of AGMRNS
04-05-16Final ResultsRNS
26-04-16ImmuPharma schedules FY results StockMarketWire
26-04-16Notice of ResultsRNS
22-04-16Holding(s) in CompanyRNS
09-03-16ImmuPharma starts European patient recruitment for Lupuzor trial StockMarketWire
09-03-16First European Site Opens - Patient RecruitmentRNS
08-03-16Holding(s) in CompanyRNS
07-03-16Holding(s) in CompanyRNS
01-03-16EIS and VCT Qualifying Status and Issue of EquityRNS
29-02-16Holding(s) in CompanyRNS
24-02-16ImmuPharma raises GBP7.7mStockMarketWire
24-02-16Issue of EquityRNS
22-02-16ImmuPharma fundraising approved StockMarketWire
22-02-16Result of GMRNS
15-02-16Dosing starts for ImmuPharma's Lupuzor trial StockMarketWire
15-02-16US PATIENTS COMMENCE DOSING IN PHASE III STUDYRNS
05-02-16ImmuPharma raises GBP8.3m via placingStockMarketWire
05-02-16Placing and Subscription Raises £8.3 millionRNS
05-02-16ImmuPharma fundraising to finance Lupuzor trial StockMarketWire
05-02-16Proposed Placing and SubscriptionRNS
21-01-16Holding(s) in CompanyRNS
15-12-15ImmuPharma update on Lupuzor StockMarketWire
15-12-15ImmuPharma & Simbec-Orion - Investigators MeetingRNS
08-12-15Should You Buy KAZ Minerals PLC & ImmuPharma PLC On Tuesday?Motley Fool
07-12-15ImmuPharma update on recruiting for Lupuzor trialStockMarketWire
07-12-15Update on the progress of LupuzorRNS
30-11-15Holding(s) in CompanyRNS
04-11-15Lupuzor Phase III Pivotal Trial UpdateRNS
04-11-15ImmuPharma update on Lupuzor trial StockMarketWire
04-11-15Lupuzor Phase III Pivotal Trial UpdateRNS
23-10-15ImmuPharma non-exec steps down StockMarketWire
23-10-15Directorate ChangeRNS
30-09-15Directorate ChangeRNS
30-09-15Interim ResultsRNS
29-07-15ImmuPharma chairman dies StockMarketWire
29-07-15Richard WarrRNS
27-07-15ImmuPharma clinical trials of Lupuzor 'live' StockMarketWire
27-07-15TERM SHEET SIGNED $14 MILLION FUNDING FOR LUPUZORRNS

RSS feeds

  • Editorial news feed for LSE:IMM Editorial
  • Regulatory news feed for LSE:IMM Regulatory